Literature DB >> 20524650

An MM/3D-RISM approach for ligand binding affinities.

Samuel Genheden1, Tyler Luchko, Sergey Gusarov, Andriy Kovalenko, Ulf Ryde.   

Abstract

We have modified the popular MM/PBSA or MM/GBSA approaches (molecular mechanics for a biomolecule, combined with a Poisson-Boltzmann or generalized Born electrostatic and surface area nonelectrostatic solvation energy) by employing instead the statistical-mechanical, three-dimensional molecular theory of solvation (also known as 3D reference interaction site model, or 3D-RISM-KH) coupled with molecular mechanics or molecular dynamics ( Blinov , N. ; et al. Biophys. J. 2010 ; Luchko , T. ; et al. J. Chem. Theory Comput. 2010 ). Unlike the PBSA or GBSA semiempirical approaches, the 3D-RISM-KH theory yields a full molecular picture of the solvation structure and thermodynamics from the first principles, with proper account of chemical specificities of both solvent and biomolecules, such as hydrogen bonding, hydrophobic interactions, salt bridges, etc. We test the method on the binding of seven biotin analogues to avidin in aqueous solution and show it to work well in predicting the ligand-binding affinities. We have compared the results of 3D-RISM-KH with four different generalized Born and two Poisson-Boltzmann methods. They give absolute binding energies that differ by up to 208 kJ/mol and mean absolute deviations in the relative affinities of 10-43 kJ/mol.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20524650     DOI: 10.1021/jp101461s

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  30 in total

1.  Binding affinities in the SAMPL3 trypsin and host-guest blind tests estimated with the MM/PBSA and LIE methods.

Authors:  Paulius Mikulskis; Samuel Genheden; Patrik Rydberg; Lars Sandberg; Lars Olsen; Ulf Ryde
Journal:  J Comput Aided Mol Des       Date:  2011-12-25       Impact factor: 3.686

2.  Absolute free energy of binding of avidin/biotin, revisited.

Authors:  Ignacio J General; Ralitsa Dragomirova; Hagai Meirovitch
Journal:  J Phys Chem B       Date:  2012-02-27       Impact factor: 2.991

3.  A 3D-RISM/RISM study of the oseltamivir binding efficiency with the wild-type and resistance-associated mutant forms of the viral influenza B neuraminidase.

Authors:  Jiraphorn Phanich; Thanyada Rungrotmongkol; Daniel Sindhikara; Saree Phongphanphanee; Norio Yoshida; Fumio Hirata; Nawee Kungwan; Supot Hannongbua
Journal:  Protein Sci       Date:  2015-06-22       Impact factor: 6.725

4.  Assessing protein-ligand binding modes with computational tools: the case of PDE4B.

Authors:  Gülşah Çifci; Viktorya Aviyente; E Demet Akten; Gerald Monard
Journal:  J Comput Aided Mol Des       Date:  2017-05-22       Impact factor: 3.686

5.  MM/GBSA and LIE estimates of host-guest affinities: dependence on charges and solvation model.

Authors:  Samuel Genheden
Journal:  J Comput Aided Mol Des       Date:  2011-11-19       Impact factor: 3.686

6.  Develop and test a solvent accessible surface area-based model in conformational entropy calculations.

Authors:  Junmei Wang; Tingjun Hou
Journal:  J Chem Inf Model       Date:  2012-04-24       Impact factor: 4.956

7.  Simple electrolyte solutions: comparison of DRISM and molecular dynamics results for alkali halide solutions.

Authors:  In Suk Joung; Tyler Luchko; David A Case
Journal:  J Chem Phys       Date:  2013-01-28       Impact factor: 3.488

8.  Small molecule hydration energy and entropy from 3D-RISM.

Authors:  J Johnson; D A Case; T Yamazaki; S Gusarov; A Kovalenko; T Luchko
Journal:  J Phys Condens Matter       Date:  2016-07-01       Impact factor: 2.333

9.  Continuum Electrostatic Behavior of a 3D-RISM Theory.

Authors:  Benoît Roux
Journal:  J Phys Chem B       Date:  2020-08-17       Impact factor: 2.991

10.  Effects of Zn2+ binding on the structural and dynamic properties of amyloid β peptide associated with Alzheimer's disease: Asp1 or Glu11?

Authors:  Liang Xu; Xiaojuan Wang; Xicheng Wang
Journal:  ACS Chem Neurosci       Date:  2013-09-13       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.